Ulrich Geilinger

Ulrich Geilinger is a Partner at HBM Partners, a prominent European investment firm specializing in public and private pharma, biopharma, and healthcare companies, including spin-offs and buyouts, managing approximately $1.5 billion in assets. He previously served as the President of SECA (Swiss Private Equity & Corporate Finance Association). With a rich background in venture capital and private equity, Ulrich is keen on fostering connections within the target industries and the venture capital realm. His expertise lies in private equity investments, particularly in spin-offs and buyouts within the biopharma and healthcare sectors. Ulrich pursued his Dr. sc. techn. studies at ETH Zürich and held key roles such as Senior Partner and Head of Private Equity at HBM Partners AG, along with being a Private Equity Investment Advisor at Bank J. Vontobel.